C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis.
CONCLUSIONS: The current evidence indicated that c-Met over expression is significantly associated with a poorer prognosis in EC. C-Met may serve as a potential novel prognostic biomarker for EC patients.
PMID: 27636117 [PubMed - as supplied by publisher]
Source: Panminerva Medica - Category: Journals (General) Tags: Panminerva Med Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Esophagus Cancer | General Medicine | Science | Skin Cancer | Squamous Cell Carcinoma | Statistics | Study